HUDECOVA, Sona, Jana MARKOVA, Veronika SIMKO, Lucia CSADEROVA, Tibor STRAČINA, Marta SIROVA, Michaela FOJTŮ, Eliska SVASTOVA, Paulina GRONESOVA, Michal PASTOREK, Marie NOVÁKOVÁ, Dana CHOLUJOVA, Juraj KOPACEK, Silvia PASTOREKOVA, Jan SEDLAK and Olga KRIZANOVA. Sulforaphane-induced apoptosis involves the type 1 IP3 receptor. Oncotarget. Albany: Impact Journals LLC, 2016, vol. 7, No 38, p. 61403-61418. ISSN 1949-2553.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Sulforaphane-induced apoptosis involves the type 1 IP3 receptor
Authors HUDECOVA, Sona (703 Slovakia), Jana MARKOVA (703 Slovakia), Veronika SIMKO (703 Slovakia), Lucia CSADEROVA (703 Slovakia), Tibor STRAČINA (703 Slovakia, belonging to the institution), Marta SIROVA (703 Slovakia), Michaela FOJTŮ (203 Czech Republic, belonging to the institution), Eliska SVASTOVA (703 Slovakia), Paulina GRONESOVA (703 Slovakia), Michal PASTOREK (703 Slovakia), Marie NOVÁKOVÁ (203 Czech Republic, guarantor, belonging to the institution), Dana CHOLUJOVA (703 Slovakia), Juraj KOPACEK (703 Slovakia), Silvia PASTOREKOVA (703 Slovakia), Jan SEDLAK (703 Slovakia) and Olga KRIZANOVA (703 Slovakia).
Edition Oncotarget, Albany, Impact Journals LLC, 2016, 1949-2553.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30105 Physiology
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 5.168
RIV identification code RIV/00216224:14110/16:00091552
Organization unit Faculty of Medicine
UT WoS 000387164700045
Keywords in English type 1 IP3 receptor; sulforaphane; apoptosis. NRF2; nude mice
Tags EL OK
Tags International impact, Reviewed
Changed by Changed by: Ing. Mgr. Věra Pospíšilíková, učo 9005. Changed: 10/1/2017 10:54.
Abstract
In this study we show that anti-tumor effect of sulforaphane (SFN) is partially realized through the type 1 inositol 1,4,5-trisphosphate receptor (IP3R1). This effect was verified in vitro on three different stable cell lines and also in vivo on the model of nude mice with developed tumors. Early response (6 hours) of A2780 ovarian carcinoma cells to SFN treatment involves generation of mitochondrial ROS and increased transcription of NRF2 and its downstream regulated genes including heme oxygenase 1, NAD(P)H:quinine oxidoreductase 1, and KLF9. Prolonged SFN treatment (24 hours) upregulated expression of NRF2 and IP3R1. SFN induces a time-dependent phosphorylation wave of HSP27. Use of IP3R inhibitor Xestospongin C (Xest) attenuates both SFN-induced apoptosis and the level of NRF2 protein expression. In addition, Xest partially attenuates anti-tumor effect of SFN in vivo. SFN-induced apoptosis is completely inhibited by silencing of IP3R1 gene but only partially blocked by silencing of NRF2; silencing of IP3R2 and IP3R3 had no effect on these cells. Xest inhibitor does not significantly modify SFN-induced increase in the rapid activity of ARE and AP1 responsive elements. We found that Xest effectively reverses the SFN-dependent increase of nuclear content and decrease of reticular calcium content. In addition, immunofluorescent staining with IP3R1 antibody revealed that SFN treatment induces translocation of IP3R1 to the nucleus. Our results clearly show that IP3R1 is involved in SFN-induced apoptosis through the depletion of reticular calcium and modulation of transcription factors through nuclear calcium up-regulation.
PrintDisplayed: 27/5/2024 09:19